Assessing Post-Marketing Requirements for Orphan Drugs: A Cross-Sectional Analysis of FDA and EMA Oversight : Clinical Pharmacology and Therapeutics

Thumbnail Image

Files

Clin Pharma and Therapeutics - 2024 - Yu - Assessing Post‐Marketing Requirements for Orphan Drugs A Cross‐Sectional.pdf (1.44 MB)

Date

2024-09-03

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Wiley

Abstract

Description

Keywords

Citation

URI

http://98.70.32.231:4000/handle/123456789/1339

Collections

Articles-Health Sciences(ACP)